Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

for
Advanced Cancer, Metastatic Solid Tumor
Location: Cleveland OH
Sponsor: Biocity Biopharmaceutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT06548672

Phase 1, Recruiting

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

for
Breast Cancer
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: Female

Age: 18+

Code: NCT04265872

Early Phase 1, Recruiting

Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Montreal
Sponsor: McGill University

Sex: Female

Age: 19 - 65

Code: NCT00764972

Phase 1, Phase 2, Recruiting

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

for
Solid Tumors
Location: Boston MA, Montreal, Durham NC, Toronto, Atlanta GA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05203172

Phase 4, Recruiting

Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

for
Breast Cancer
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05736367

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluation of the Bexa Breast Examination

for
Breast Cancer
Location: Abilene TX
Sponsor: Sure, Inc.

Sex: Female

Age: 30 - 70+

Code: NCT06643767

Recruiting

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: New York NY, Baltimore MD, Richmond VA, Aventura FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03606967

Phase 2, Recruiting

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

for
Breast Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT02772367

Recruiting

Testicular Tissue Cryopreservation for Fertility Preservation

for
Cancer, Autoimmune Disorders
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Male

Age: 0+

Code: NCT02972801

Recruiting

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

for
Pulmonary Hemorrhage, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05053867

Phase 3, Recruiting

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

for
Prostate Cancer,
Location: New York NY, Philadelphia PA
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT00503646

Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase 1, Phase 2, Recruiting

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Atlanta GA, Louisville KY, Fairway KS, Dallas TX,
Sponsor: Impact Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04768868

Phase 1, Recruiting

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Providence RI, East Brunswick NJ, Toronto, Sarasota FL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05875168

Phase 1, Phase 2, Recruiting

Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy

for
Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT00026650

Recruiting

Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors

for
Solid Tumor, Cancer Metastatic
Location: Woburn MA, Portland OR
Sponsor: CanWell Pharma Inc.

Sex: All

Age: 18 - 70+

Code: NCT04987112

Phase 1, Recruiting

Magnetic Resonance Imaging of Breast Cancer

for
Breast Cancer, Breast Cancer Non-invasive Breast Cancer
Location: Stanford CA
Sponsor: Stanford University

Sex: Female

Age: 21+

Code: NCT01035112

Recruiting

Novel Magnetic Resonance Imaging-Guided Ultrasound-Stimulated Microbubble Radiation Treatment for Patients With Chest-Wall and Breast Cancer

for
Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT06185972

Phase 2, Recruiting

Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05178472

Recruiting

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

for
Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer,
Location: Austin TX, San Antonio TX, Scottsdale AZ
Sponsor: OncoResponse, Inc.

Sex: All

Age: 18+

Code: NCT05094804

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial